Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine
Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2020-10, Vol.383 (18), p.e101-e101 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e101 |
|---|---|
| container_issue | 18 |
| container_start_page | e101 |
| container_title | The New England journal of medicine |
| container_volume | 383 |
| creator | Gandhi, Monica Rutherford, George W |
| description | Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths. |
| doi_str_mv | 10.1056/NEJMp2026913 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7890559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2455577610</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-ab486128fa06a3797b9c0361288716f0a141b708322da69d45da11f9bd0aa8923</originalsourceid><addsrcrecordid>eNptkctOFEEUhitEIiO6c20qkQULG-vSdduYkAkKBNSFwrJyursaa-zuGqt6MO7mIVzKy82TUJMBgsazOck5X_5z-RF6SckBJUK-_Xh0ej5nhElD-RaaUMF5UZZEPkETQpguSmX4DnqW0ozkoKV5inY400ZJSSfo63uoPXT4HNJ3P1zhNkQ8Dde-KajBq-Vv_DmMbhjXyLq1Wv65gOhDB6MPw2p5gyHhS4cPf4IfMeALqGs_uOdou4UuuRd3eTfPOfoyPS7OPn04mR6eFbWgbCygKrWkTLdAJHBlVGVqwtcVrahsCdCSVopozlgD0jSlaIDS1lQNAdCG8V30bqM7X1S9a-q8aYTOzqPvIf6yAbz9uzP4b_YqXFulDRHCZIH9O4EYfixcGm3vU-26DgYXFsmy_ElDuFI6o6__QWdhEYd8XqaEEEpJSjL1ZkPVMaQUXfuwDCV27Zd97FfGXz0-4AG-NygDexug75Md3Kz_v84tKIWbyA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2455577610</pqid></control><display><type>article</type><title>Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Gandhi, Monica ; Rutherford, George W</creator><creatorcontrib>Gandhi, Monica ; Rutherford, George W</creatorcontrib><description>Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMp2026913</identifier><identifier>PMID: 32897661</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Asymptomatic ; Asymptomatic Infections ; Betacoronavirus ; Communicable Disease Control - methods ; Coronavirus Infections - prevention & control ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Disease transmission ; Epidemics ; Fatalities ; Humans ; Hypotheses ; Immunity, Cellular ; Immunization ; Infections ; Masks ; Pandemics ; Pandemics - prevention & control ; Pathogenesis ; Pneumonia, Viral - prevention & control ; Population ; Public health ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Smallpox ; Viral infections ; Viruses</subject><ispartof>The New England journal of medicine, 2020-10, Vol.383 (18), p.e101-e101</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-ab486128fa06a3797b9c0361288716f0a141b708322da69d45da11f9bd0aa8923</citedby><cites>FETCH-LOGICAL-c512t-ab486128fa06a3797b9c0361288716f0a141b708322da69d45da11f9bd0aa8923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMp2026913$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2455577610?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,2759,2760,26103,27924,27925,52382,54064,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32897661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gandhi, Monica</creatorcontrib><creatorcontrib>Rutherford, George W</creatorcontrib><title>Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.</description><subject>Asymptomatic</subject><subject>Asymptomatic Infections</subject><subject>Betacoronavirus</subject><subject>Communicable Disease Control - methods</subject><subject>Coronavirus Infections - prevention & control</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Fatalities</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Immunity, Cellular</subject><subject>Immunization</subject><subject>Infections</subject><subject>Masks</subject><subject>Pandemics</subject><subject>Pandemics - prevention & control</subject><subject>Pathogenesis</subject><subject>Pneumonia, Viral - prevention & control</subject><subject>Population</subject><subject>Public health</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Smallpox</subject><subject>Viral infections</subject><subject>Viruses</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkctOFEEUhitEIiO6c20qkQULG-vSdduYkAkKBNSFwrJyursaa-zuGqt6MO7mIVzKy82TUJMBgsazOck5X_5z-RF6SckBJUK-_Xh0ej5nhElD-RaaUMF5UZZEPkETQpguSmX4DnqW0ozkoKV5inY400ZJSSfo63uoPXT4HNJ3P1zhNkQ8Dde-KajBq-Vv_DmMbhjXyLq1Wv65gOhDB6MPw2p5gyHhS4cPf4IfMeALqGs_uOdou4UuuRd3eTfPOfoyPS7OPn04mR6eFbWgbCygKrWkTLdAJHBlVGVqwtcVrahsCdCSVopozlgD0jSlaIDS1lQNAdCG8V30bqM7X1S9a-q8aYTOzqPvIf6yAbz9uzP4b_YqXFulDRHCZIH9O4EYfixcGm3vU-26DgYXFsmy_ElDuFI6o6__QWdhEYd8XqaEEEpJSjL1ZkPVMaQUXfuwDCV27Zd97FfGXz0-4AG-NygDexug75Md3Kz_v84tKIWbyA</recordid><startdate>20201029</startdate><enddate>20201029</enddate><creator>Gandhi, Monica</creator><creator>Rutherford, George W</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201029</creationdate><title>Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine</title><author>Gandhi, Monica ; Rutherford, George W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-ab486128fa06a3797b9c0361288716f0a141b708322da69d45da11f9bd0aa8923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Asymptomatic</topic><topic>Asymptomatic Infections</topic><topic>Betacoronavirus</topic><topic>Communicable Disease Control - methods</topic><topic>Coronavirus Infections - prevention & control</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Fatalities</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Immunity, Cellular</topic><topic>Immunization</topic><topic>Infections</topic><topic>Masks</topic><topic>Pandemics</topic><topic>Pandemics - prevention & control</topic><topic>Pathogenesis</topic><topic>Pneumonia, Viral - prevention & control</topic><topic>Population</topic><topic>Public health</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Smallpox</topic><topic>Viral infections</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gandhi, Monica</creatorcontrib><creatorcontrib>Rutherford, George W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gandhi, Monica</au><au>Rutherford, George W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2020-10-29</date><risdate>2020</risdate><volume>383</volume><issue>18</issue><spage>e101</spage><epage>e101</epage><pages>e101-e101</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>32897661</pmid><doi>10.1056/NEJMp2026913</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2020-10, Vol.383 (18), p.e101-e101 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7890559 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Asymptomatic Asymptomatic Infections Betacoronavirus Communicable Disease Control - methods Coronavirus Infections - prevention & control Coronaviruses COVID-19 COVID-19 vaccines Disease transmission Epidemics Fatalities Humans Hypotheses Immunity, Cellular Immunization Infections Masks Pandemics Pandemics - prevention & control Pathogenesis Pneumonia, Viral - prevention & control Population Public health SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Smallpox Viral infections Viruses |
| title | Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T06%3A23%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Facial%20Masking%20for%20Covid-19%20%E2%80%94%20Potential%20for%20%E2%80%9CVariolation%E2%80%9D%20as%20We%20Await%20a%20Vaccine&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Gandhi,%20Monica&rft.date=2020-10-29&rft.volume=383&rft.issue=18&rft.spage=e101&rft.epage=e101&rft.pages=e101-e101&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMp2026913&rft_dat=%3Cproquest_pubme%3E2455577610%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2455577610&rft_id=info:pmid/32897661&rfr_iscdi=true |